Trump, Zepbound and Weight Loss Drugs
Digest more
The White House is in discussions with the makers of weight loss drugs Wegovy and Zepbound to drastically lower prices, NBC News has learned. The prices could drop from an average price of $1,300 a month to $150 a month,
President Donald Trump announced that his administration has finally struck a deal with Novo Nordisk and Eli Lilly to reduce the cost of their GLP-1 weight loss drugs, Wegovy and Zepbound. Currently,
4hon MSN
Ozempic Is About to Go on Sale
Even after Trump’s new deal, obesity drugs are still too expensive.
Everyday Health on MSN
White House Slashes GLP-1 Costs, Permits Medicare Coverage for Obesity
A deal with drugmakers also means that Medicare would cover obesity drugs for the first time. But certain limitations persist.
The Trump administration is currently negotiating with Danish pharmaceuticals, including Eli Lilly and Novo Nordisk to minimize the cost of glucagon-like peptide-1 GLP-1 drugs — weight-loss pills.Several credible sources informed ABC
Feedback